Category: Brazil
-
AI opportunities, UK interim license frustration and global SEP injunction divergence: highlights from Via’s Business Summit in Rome
ip fray breaks down some of the highlights of Via Licensing Alliance’s third-ever Business Summit in Rome this week, where it took part as official media partner and one of the panel moderators.
-
Pendulum swings in Nokia’s favor in Brazilian ASUS preliminary injunction case
Nokia has received a favorable expert report in a Brazilian merits-based preliminary injunction case against ASUS.
-
UPC receives first complaint from Brazil: Silimed sues Polytech for patent infringement
Brazilian implant manufacturer Silimed has taken its long-running dispute with Polytech over polyurethane-coated breast implant technology to the UPC. The case follows Silimed’s recent success in German entitlement proceedings.
-
InterDigital files patent infringement actions against Hisense, TCL in UPC, Germany, Brazil, India; TCL also in U.S.
InterDigital has a very successful licensing program and needs to litigate only in a minority of cases. Launching enforcement actions in four (TCL: five) jurisdictions in parallel is a strong statement.
-
NEC wins Brazilian preliminary injunction against HMD based on expert report: HMD could settle through Via pool license
HMD has previously been sued in Brazil by VoiceAge EVS. Now it also has to comply with an injunction obtained by NEC.
-
Hisense in trouble in Brazil as court imposes sanctions for litigation misconduct despite settlement through Access Advance pool license
The Rio de Janeiro State Court decided to pursue sanctions against Hisense regardless of a settlement after which JVC no longer asked for them.
-
ZTE defeats Samsung again as Brazilian appeals court reinstates 5G injunction, declines to give Samsung “free pass to infringe” and hold out
ZTE’s impressive winning streak continues, and Samsung now has to give serious consideration to a settlement as the noose is tightening.
-
Roche’s Genentech, Organon, China’s Henlius settle major pertuzumab biosimilar litigation in U.S., UPC, NL, and Brazil (where it was most advanced)
A favorable validity decision by the Brazilian patent office and evidence preservation in the UPC contributed to this important biosimilar settlement.
-
BREAKING: First-ever major SEP infringement suits in South Africa, Vietnam, Thailand, the Philippines – Ericsson files third wave against Transsion
Ericsson has now sued Transsion in 11 different jurisdictions, six of which have never received any SEP infringement actions before.